Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 46201-46250 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06105489
"Tunnel Flap vs Trapezoidal Flap for Lateral Sinus Lift"
NARecruiting
36 participants
Started: Oct 21, 2022 · Completed: Oct 21, 2026
1 condition1 sponsor1 location
NCT06425848
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
N/ARecruiting
2,000 participants
Started: Oct 21, 2022 · Completed: Dec 31, 2030
1 condition1 sponsor12 locations
NCT05535088
Older Adults Virtual Reality
NARecruiting
35 participants
Started: Oct 20, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05408754
Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation
NARecruiting
78 participants
Started: Oct 20, 2022 · Completed: May 1, 2025
1 condition1 sponsor6 locations
NCT05685836
89Zr-Bevacizumab PET/CT Imaging in NF2 Patients
N/ARecruiting
15 participants
Started: Oct 20, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05190978
Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction
NARecruiting
120 participants
Started: Oct 20, 2022 · Completed: Apr 30, 2026
2 conditions7 sponsors1 location
NCT05652374
Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study
PHASE4Recruiting
100 participants
Started: Oct 20, 2022 · Completed: Oct 31, 2027
1 condition3 sponsors3 locations
NCT05496348
Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis
N/ARecruiting
400 participants
Started: Oct 20, 2022 · Completed: Aug 31, 2027
1 condition1 sponsor94 locations
NCT04931979
SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy
PHASE2Recruiting
49 participants
Started: Oct 20, 2022 · Completed: Apr 1, 2026
2 conditions2 sponsors1 location
NCT05500586
The Effects of Glucagon on Hepatic Metabolism
PHASE1/PHASE2Recruiting
60 participants
Started: Oct 20, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05390918
Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
NARecruiting
190 participants
Started: Oct 20, 2022 · Completed: Jul 31, 2026
3 conditions2 sponsors1 location
NCT05086250
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
EARLY_PHASE1Recruiting
20 participants
Started: Oct 20, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04535050
DENEX Renal Denervation in Patients With Hypertension on no Antihypertensive Medications
NARecruiting
100 participants
Started: Oct 20, 2022 · Completed: Apr 15, 2026
3 conditions1 sponsor1 location
NCT05598034
Evaluating tDCS Brain-stimulation in Depression Using MRI
NARecruiting
144 participants
Started: Oct 20, 2022 · Completed: May 1, 2027
1 condition2 sponsors1 location
NCT05571774
Construction of a Database for TTP
N/ARecruiting
500 participants
Started: Oct 20, 2022 · Completed: Oct 20, 2028
1 condition1 sponsor1 location
NCT05547321
Efficacy and Safety Study of OMTX705, Monotherapy and Pembrolizumab-combined, in Subjects With Advanced Solid Tumors.
PHASE1Recruiting
120 participants
Started: Oct 20, 2022 · Completed: Oct 31, 2024
1 condition1 sponsor8 locations
NCT05950698
Obesity and Bariatric Surgery According to a Biopsychosocial Perspective.
N/ARecruiting
50 participants
Started: Oct 20, 2022 · Completed: Oct 20, 2026
5 conditions3 sponsors1 location
NCT05122728
Post-Concussion Musculoskeletal Injury Risks
N/ARecruiting
148 participants
Started: Oct 20, 2022 · Completed: Dec 1, 2025
1 condition3 sponsors3 locations
NCT05566392
Longterm Influence of Pediatric Long COVID Syndrome
N/ARecruiting
500 participants
Started: Oct 20, 2022 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT05259839
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma
PHASE1Recruiting
320 participants
Started: Oct 20, 2022 · Completed: Sep 30, 2033
1 condition1 sponsor49 locations
NCT05049148
Platelets Activation in Brain Neoplasms
NARecruiting
50 participants
Started: Oct 20, 2022 · Completed: Jan 20, 2028
4 conditions1 sponsor1 location
NCT05500469
Endothelial Cell Loss in Pseudophakic Patients Receiving a Paul Glaucoma Drainage Device With Its Tube Inserted in the Anterior Versus Posterior Chamber: a Randomized Controlled Trial
NARecruiting
200 participants
Started: Oct 20, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06231446
Extracorporeal Membrane Oxygenation for Respiratory Failure Patients
N/ARecruiting
400 participants
Started: Oct 20, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05581004
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
PHASE1Recruiting
450 participants
Started: Oct 20, 2022 · Completed: Feb 28, 2027
12 conditions1 sponsor41 locations
NCT05232630
Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes
PHASE4Recruiting
20 participants
Started: Oct 20, 2022 · Completed: Jun 20, 2025
6 conditions2 sponsors1 location
NCT05586022
Risk Factors for Adverse Outcomes of Endovascular Revascularization in Lower Extremity Arteriosclerosis Occlusion
N/ARecruiting
500 participants
Started: Oct 20, 2022 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT06170268
Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
N/ARecruiting
20,000 participants
Started: Oct 20, 2022 · Completed: Dec 31, 2032
1 condition5 sponsors1 location
NCT05595590
Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer
PHASE2Recruiting
20 participants
Started: Oct 20, 2022 · Completed: Oct 19, 2026
1 condition1 sponsor2 locations
NCT05611593
Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia
PHASE1Recruiting
90 participants
Started: Oct 20, 2022 · Completed: Feb 28, 2025
1 condition1 sponsor3 locations
NCT05493163
Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism
PHASE4Recruiting
558 participants
Started: Oct 19, 2022 · Completed: Jan 31, 2028
1 condition9 sponsors1 location
NCT05861752
Paraphilic Disorders and Other Conditions with Risk for Sexual Violence: a Case-control Study
N/ARecruiting
240 participants
Started: Oct 19, 2022 · Completed: Oct 19, 2037
3 conditions2 sponsors1 location
NCT05344651
Comparing the Baerveldt and Paul Glaucoma Drainage Devices and Their Effects on the Corneal Endothelium
NARecruiting
160 participants
Started: Oct 19, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05605197
U87 CART in Treatment of Advanced Solid Tumor
PHASE1Recruiting
12 participants
Started: Oct 19, 2022 · Completed: Oct 8, 2025
2 conditions2 sponsors1 location
NCT04869683
Biocollection in MyeloDysplastic Syndrome (P-MDS)
NARecruiting
150 participants
Started: Oct 19, 2022 · Completed: Oct 19, 2032
6 conditions1 sponsor1 location
NCT05626985
Refinement and Validation of a Diagnostic Model (GAMAD) for Early Detection of Hepatocellular Carcinoma
N/ARecruiting
2,000 participants
Started: Oct 19, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors3 locations
NCT05599685
A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer
N/ARecruiting
150 participants
Started: Oct 19, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT04755413
The Precision CAD Trial
NARecruiting
450 participants
Started: Oct 19, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor5 locations
NCT06955208
3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features
NARecruiting
300 participants
Started: Oct 19, 2022 · Completed: Oct 9, 2026
1 condition1 sponsor1 location
NCT04972799
Evaluation of the Efficacy and Safety of Autologous Fat Injection Into the Intersphincter Space in Fecal Incontinence: a Randomized, Placebo-controlled, Cross-over, Double-blind Trial
NARecruiting
50 participants
Started: Oct 19, 2022 · Completed: Nov 30, 2027
1 condition1 sponsor3 locations
NCT06522815
Updating Deep Learning Algorithms for OSA Monitoring
NARecruiting
107 participants
Started: Oct 19, 2022 · Completed: Jul 11, 2025
2 conditions2 sponsors1 location
NCT05397197
Impact of Moderate Preterm Birth on Vocabulary Acquisition
NARecruiting
160 participants
Started: Oct 19, 2022 · Completed: Oct 18, 2027
1 condition1 sponsor1 location
NCT06805552
Sarcopenia and Systemic Therapy in HCC
N/ARecruiting
270 participants
Started: Oct 19, 2022 · Completed: Nov 1, 2025
1 condition2 sponsors1 location
NCT04991025
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
PHASE2Recruiting
60 participants
Started: Oct 19, 2022 · Completed: Oct 31, 2026
3 conditions1 sponsor7 locations
NCT06239584
Generation of Lung Tumor Organoids From Patients Undergoing Diagnostic Bronchoscopy
NARecruiting
30 participants
Started: Oct 19, 2022 · Completed: Feb 2, 2024
1 condition2 sponsors1 location
NCT05566561
Para-sartorial Compartment Block in Knee Surgery
NARecruiting
60 participants
Started: Oct 19, 2022 · Completed: Dec 16, 2025
4 conditions1 sponsor1 location
NCT04930653
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
PHASE2Recruiting
34 participants
Started: Oct 19, 2022 · Completed: Jun 15, 2028
8 conditions2 sponsors3 locations
NCT05368428
Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer
NARecruiting
27 participants
Started: Oct 19, 2022 · Completed: Mar 31, 2027
22 conditions2 sponsors3 locations
NCT05692739
Clinical Trial to Determine the Effectiveness and Safety of Topical Insulin in Dry Eye
PHASE4Recruiting
120 participants
Started: Oct 19, 2022 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT05687968
Innovative Approaches in Diabetes Care
NARecruiting
39 participants
Started: Oct 19, 2022 · Completed: Oct 1, 2025
3 conditions1 sponsor1 location
NCT06017011
Clinico-Radiological Characterisation for Remission of Acute Charcot-Neuroarthropathy of Foot.
N/ARecruiting
25 participants
Started: Oct 19, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location